Grosso A, Locatelli F, Gini E, Albicini F, Tirelli C, Cerveri I, Corsico A G
1Division of Respiratory Diseases, IRCCS "San Matteo" Hospital Foundation, University of Pavia, Vaile C. Golgi 19, 27100 Pavia, Italy.
2Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Allergy Asthma Clin Immunol. 2018 Apr 17;14:16. doi: 10.1186/s13223-018-0242-0. eCollection 2018.
Over the years it has been widely stated that approximately one-third of asthmatic women experience worsening of the disease during pregnancy. However, the literature has not been reviewed systematically and the meta-analytic reviews include old studies. This study aimed to examine whether the prevalence of worsening asthma during pregnancy is still consistent with prior estimate or it has been reduced.
A detailed Clinical Questionnaire on respiratory symptoms, medical history, medication, use of services, occupation, social status, home environment and lifestyle was administered to random samples of the Italian population in the frame of the Gene Environment Interactions in Respiratory Diseases (GEIRD) study. Only clinical data belong to 2.606 subjects that completed the clinical stage of the GEIRD study, were used for the present study.
Out of 1.351 women, 284 self-reported asthma and 92 of them had at least one pregnancy. When we considered the asthma course during pregnancy, we found that 16 women worsened, 31 remained unchanged, 25 improved. Seven women had not the same course in the different pregnancies and 13 did not know. The starting age of ICS use almost overlaps with that of asthma onset in women with worsening asthma during pregnancy (19 years ± 1.4), unlike the other women who started to use ICS much later (30.3 years ± 12). In addition, the worsening of asthma was more frequent in women with an older age of onset of asthma (18 years ± 9 vs 13 years ± 10). Among women who completed the ACT during the clinical interview, the 50% of women who experienced worsening asthma during pregnancy (6/12) had an ACT score below 20.
Asthma was observed to worsen during pregnancy in a percentage much lower to that generally reported in all the previous studies. There is still room in clinical practice to further reduce worsening of asthma during pregnancy by improving asthma control, with a more structured approach to asthma education and management prepregnancy.
多年来,人们普遍认为约三分之一的哮喘女性在孕期病情会加重。然而,相关文献尚未得到系统综述,且荟萃分析所纳入的研究较为陈旧。本研究旨在探讨孕期哮喘病情加重的发生率是否仍与先前估计一致,或者是否有所降低。
在“呼吸系统疾病基因-环境相互作用”(GEIRD)研究框架下,对意大利人群随机样本进行了一份详细的关于呼吸症状、病史、用药情况、服务使用情况、职业、社会地位、家庭环境和生活方式的临床问卷调查。本研究仅使用了GEIRD研究临床阶段完成的2606名受试者的临床数据。
在1351名女性中,284人自述患有哮喘,其中92人至少经历过一次怀孕。当我们考虑孕期哮喘病程时,发现16名女性病情加重,31名病情未变,25名病情改善。7名女性在不同孕期病情变化不同,13名女性不清楚。孕期哮喘病情加重的女性开始使用吸入性糖皮质激素(ICS)的起始年龄与哮喘发病年龄几乎重叠(19岁±1.4),而其他女性开始使用ICS的时间要晚得多(30.3岁±12)。此外,哮喘发病年龄较大的女性哮喘病情加重更为频繁(18岁±9比13岁±10)。在临床访谈中完成哮喘控制测试(ACT)的女性中,孕期哮喘病情加重的女性中有50%(6/12)的ACT评分低于20。
观察到孕期哮喘病情加重的比例远低于以往所有研究中普遍报道的比例。在临床实践中,仍有空间通过改善哮喘控制,采用更结构化的哮喘教育和孕前管理方法,进一步降低孕期哮喘病情加重的情况。